This variability likely reflects differences in study populations, such as the presence or absence of T2DM, degree of obesity, sex distribution, and comorbid conditions, as well as differences in intervention characteristics, including the type, dose, and duration of GLP-1 RA therapy
Retatrutide is a multi-receptor peptide currently being researched for metabolic support, appetite regulation, and body composition applications
Heres what the research found, and what it means for anyone managing their weight with these medications
Can lifestyle changes improve response to GLP-1 therapy
For best outcomes, treat this like a daily ritualstructured, consistent, and aligned with your larger health strategy
Special dietary considerations on GLP-1 Not every GLP-1 user eats the same way